- Home
- MFA vs CRMD Comparison
MFA vs CRMD Comparison
Compare MFA & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFA
- CRMD
- Stock Information
- Founded
- MFA 1997
- CRMD 2006
- Country
- MFA United States
- CRMD United States
- Employees
- MFA N/A
- CRMD N/A
- Industry
- MFA Real Estate Investment Trusts
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- MFA Real Estate
- CRMD Health Care
- Exchange
- MFA Nasdaq
- CRMD Nasdaq
- Market Cap
- MFA 980.3M
- CRMD 877.5M
- IPO Year
- MFA N/A
- CRMD 2010
- Fundamental
- Price
- MFA $9.14
- CRMD $11.64
- Analyst Decision
- MFA Buy
- CRMD Strong Buy
- Analyst Count
- MFA 9
- CRMD 7
- Target Price
- MFA $11.75
- CRMD $17.33
- AVG Volume (30 Days)
- MFA 1.3M
- CRMD 1.8M
- Earning Date
- MFA 08-06-2025
- CRMD 08-13-2025
- Dividend Yield
- MFA 15.77%
- CRMD N/A
- EPS Growth
- MFA N/A
- CRMD N/A
- EPS
- MFA 0.99
- CRMD 0.28
- Revenue
- MFA $292,245,000.00
- CRMD $82,553,827.00
- Revenue This Year
- MFA N/A
- CRMD $278.96
- Revenue Next Year
- MFA $12.27
- CRMD $45.85
- P/E Ratio
- MFA $9.22
- CRMD $41.93
- Revenue Growth
- MFA 52.95
- CRMD N/A
- 52 Week Low
- MFA $7.85
- CRMD $3.61
- 52 Week High
- MFA $13.45
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- MFA 40.03
- CRMD 47.40
- Support Level
- MFA $9.36
- CRMD $11.40
- Resistance Level
- MFA $9.52
- CRMD $12.02
- Average True Range (ATR)
- MFA 0.16
- CRMD 0.47
- MACD
- MFA -0.02
- CRMD 0.10
- Stochastic Oscillator
- MFA 19.80
- CRMD 68.61
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.